CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

Hot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...

When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

Hot flashes are sudden surges of sweat, sudden heat, or flushed skin. They are a common symptom of menopause. According to J ...

According to a McKinsey analysis, women spend 25% more time than men in poor health — and investments addressing the women’s ...

This article reviews the published literature on the use of venlafaxine, fluoxetine, and paroxetine for the treatment of hot flashes.

Many women in their 40s might mistake perimenopause symptoms like mood swings and fatigue for depression. As estrogen and ...

For many generations, menopause was a taboo topic. Despite 6,000 women reaching menopause in the U.S. each day, this pivotal ...

Treatment with vitamin E was allowed if it was used regularly for at least six weeks before study enrollment and continued throughout the study. Women taking other agents for hot flashes ...